Produced to the most demanding industry standards at dedicated facilities, Zephex® propellants are used in around 75% of the world’s metered dose inhalers.

This commitment to the highest levels of medical propellant quality is supported by a detailed understanding of customer requirements and experienced staff with many years of technical expertise.

Latest News

Koura logo

‘GREEN’ MEDICAL PROPELLANT RECEIVES FDA APPROVAL TO PROCEED TO CLINICAL TRIALS

BOSTON, Feb. 4, 2020 – Koura (previously known as Mexichem Fluor), a pioneer in the development of next generation propellants, today announced FDA approval to proceed to clinical trials with Zephex® 152a. This new medical propellant has been under development for several years for use…

Read More
Third student awarded the Koura Alasdair Sinclair Scholarship

Third student awarded the Koura Alasdair Sinclair Scholarship

The University of Manchester has announced Melissa Pace as the third student to receive Koura’s Alasdair Sinclair Scholarship.

Read More
Koura logo

Mexichem Fluor showcases courageous new identity

Our parent company has rebranded as Koura to reflect our bold, diverse and progressive new direction as a business. Find out more here.

Read More